AI brief of an SEC Form 8-K · Vericel (VCEL)

Vericel Q4 revenue rises 23% to $65.0 million; 2024 revenue guidance $237-$241 million

Positive Impact 3 of 5 earnings Written later

Vericel reported fourth-quarter and full-year 2023 results, with total revenue up 23% to $65.0 million in the quarter and up 20% to $197.5 million for the year. The company also issued 2024 guidance calling for total net revenue of $237 to $241 million, a gross margin of approximately 70%, and an adjusted EBITDA margin of approximately 20%. Shareholders get a view of stronger quarterly profit and a narrower full-year net loss, along with the company's first full-year revenue outlook in this release.

Key points

  • Q4 2023 net income was $13.0 million, or $0.26 per diluted share, versus $5.9 million, or $0.12 per diluted share, in Q4 2022.
  • Full-year 2023 net loss was $3.2 million, or $0.07 per diluted share, compared with a net loss of $16.7 million, or $0.35 per diluted share, in 2022.
  • MACI net revenue was $164.8 million for 2023, up 25%; Burn Care net revenue was $32.7 million.
  • As of December 31, 2023, the company had $152.6 million in cash, restricted cash and investments and no debt.

The filing

CompanyVericel (VCEL)
Form8-K, current report
Filed with the SECFeb 29, 2024, 8:04 AM ET
Accession number0001628280-24-007807

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:49 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 29, 2024.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.